Mastek Ltd
Mastek Q1 FY27 earnings call: Revenue & Margins
Q1 FY27 earnings call: what management said on revenue, margins and capex.
What the Q1 FY27 call signalled
2 of 4 strong
The short version
U.K. Mastek expects steady revenue growth driven by strong order book and AI-led initiatives, particularly in Healthcare and public sector verticals.
From Mastek Ltd's Q1 FY27 earnings-call transcript · updated 16 Oct 2026.
Revenue & Sales Performance
- U.K. business expected to continue delivering good growth and momentum.
- North America business has positive order book tailwinds; expected to turn into a growth engine by H2 FY27 after 1-2 more quarters of ramp-up.
- FY27 performance anticipated to be better than FY26, driven by order backlog and new deal pipeline.
- Middle East business faces uncertainty due to geopolitical turmoil; growth depends on stabilization but has a strong pipeline.
- AI-led initiatives driving new opportunities in existing and net new accounts across geographies.
- Healthcare vertical in U.K. and U.S. expected to ramp up strongly from Q2 and especially H2.
2 more points from Mastek Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Mastek Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Mastek is undergoing a significant AI-led business transformation internally, treating itself as "Customer Zero."
- Investments include replacing core systems of records (CRM, recruitment, payables) with AI-native, system-of-intelligence solutions.
- Focus on transforming from an engineering powerhouse to a transformation powerhouse, including upskilling resources to Forward Deployed Engineers (FDEs) and Forward Deployed Domain Consultants (FDDCs).
- AI transformation is not only client-facing but is being executed internally as a strategic investment.
2 more points from Mastek Ltd's call on capex
Create a free account to keep reading this call
Fundraising & Capital Structure
See what Mastek Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- The 12-month order backlog has grown by 25% year-on-year and 13% in constant currency terms, indicating strong order book momentum.
- The total contract value (TCV) is healthy and moving positively, exemplified by a recent $25 million, 5-year deal in North America.
- There is a good increase in the number of large deal pipeline items across geographies.
- The AI-led opportunities in the order pipeline are increasing consistently, with multiple ongoing campaigns in existing and new customers.
- Middle East has a strong order pipe, including large Healthcare deals close to signature and ramp-up, although political volatility creates some uncertainty.
2 more points from Mastek Ltd's call on order book
Create a free account to keep reading this call
Mastek Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹1.0K Cr, net profit ₹106 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Mastek's management said in earlier quarters
Others in IT - Software this season
- Delaplex (Q1 FY27)
H2 FY26 total income (quarterly equivalent): ₹340.4 Mn vs ₹328.4 Mn in H2 FY25, a 3.66% YoY increase. Key investor presentation takeaways from Delaplex Ltd's Q1
- Xelpmoc Design (Q1 FY27)
Q1 FY27 Revenue from Operations: Rs 9.6 million, up 22.5% YoY from Rs 7.8 million in Q1 FY26 (Page 27). Key investor presentation takeaways from Xelpmoc Design'
- Cybertech Sys. (Q1 FY27)
Total Revenue: ₹766.3 million, up 17.5% YoY (Page 3, 15, 19) . Key investor presentation takeaways from Cybertech Systems & Software Ltd's Q1 FY27 investor pres
- Workmates Core2 (Q1 FY27)
FY26 total revenue: ₹143 Cr (Page 10) . Key concall takeaways from Workmates Core2cloud Solution Ltd's Q1 FY27 earnings call — and how it ranks against sector…
Potential multibaggers · Q2 FY27
This quarter's potential multibaggers
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Mastek Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Mastek Ltd Q1 FY27 results?
U.K. Mastek expects steady revenue growth driven by strong order book and AI-led initiatives, particularly in Healthcare and public sector verticals.
What is Mastek Ltd share price analysis?
Mastek Ltd currently shows a below-average growth signal. The stock trades at a P/E of 12.9 with a market cap of ₹5,677 Cr. Investors should review the full earnings analysis for detailed insights.
Is Mastek Ltd planning capital expenditure?
Mastek is undergoing a significant AI-led business transformation internally, treating itself as "Customer Zero." - Investments include replacing core systems of records (CRM, recruitment, payables) with AI-native, system-of-intelligence solutions.
Keep Mastek Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.